TheraRadar
← Back
Data updated: Mar 29, 2026

INVENTIA

CardiovascularInfectious DiseaseGastroenterology
Generics

INVENTIA is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Gastroenterology.

2012
Since
11
Drugs
-
Trials
139
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PALIPERIDONE 2026-01-26
METFORMIN HYDROCHLORIDE 2025-11-10
Manufacturing (CMC)
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
LANSOPRAZOLE 2025-09-16
Labeling
OLMESARTAN MEDOXOMIL 2025-09-12
Labeling
OLMESARTAN MEDOXOMIL 2025-09-12
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
3 drugs
Infectious Disease 33%
2 drugs
Gastroenterology 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease